← Back to home

INFILTRATING BLADDER UROTHELIAL CARCINOMA WITH SQUAMOUS DIFFERENTIATION

Clinical trials for INFILTRATING BLADDER UROTHELIAL CARCINOMA WITH SQUAMOUS DIFFERENTIATION explained in plain language.

Never miss a new study

Get alerted when new INFILTRATING BLADDER UROTHELIAL CARCINOMA WITH SQUAMOUS DIFFERENTIATION trials appear

Sign up with your email to follow new studies for INFILTRATING BLADDER UROTHELIAL CARCINOMA WITH SQUAMOUS DIFFERENTIATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1

New drug duo tested in Tough-to-Treat bladder cancer

Disease control Recruiting now

This early-stage study is testing a combination of two drugs, cabozantinib and enfortumab vedotin, for advanced bladder cancer that has spread. The main goal is to find the safest and most effective dose. The study will also look for early signs that the treatment can shrink tumo…

Matched conditions: INFILTRATING BLADDER UROTHELIAL CARCINOMA WITH SQUAMOUS DIFFERENTIATION

Phase: PHASE1 • Sponsor: Emory University • Aim: Disease control

Last updated Mar 24, 2026 12:02 UTC

INFILTRATING BLADDER UROTHELIAL CARCINOMA WITH SQUAMOUS DIFFERENTIATION

Get alerted when new INFILTRATING BLADDER UROTHELIAL CARCINOMA WITH SQUAMOUS DIFFERENTIATION trials appear

New drug duo tested in Tough-to-Treat bladder cancer